# Clindamycin-trimethoprim/Sulfamethoxazole for PCP After Solid Organ Transplantation Population.

> **NCT04328688** · — · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 30 (actual)

## Conditions studied

- Pneumocystis Jirovecii Pneumonia
- Solid Organ Transplantation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04328688
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-01
- **Primary completion:** 2019-09-01
- **Final completion:** 2019-09-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04328688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04328688, "Clindamycin-trimethoprim/Sulfamethoxazole for PCP After Solid Organ Transplantation Population.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04328688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*